Therapeutic options of chronic constipation;Therapieoptionen der chronischen obstipation

Internist

Volumn 46, Issue 12, 2005, Pages 1331-1338

  Krammer, H ^a   Schlieger, F ^a   Singer, M V ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Chronic constipation; Laxatives; Polyethylene glycol; Probiotics; Tegaserod

Indexed keywords

BISACODYL; ENEMA; ISPAGULA; LAXATIVE; MACROGOL; PROBIOTIC AGENT; TEGASEROD;

CHRONIC DISEASE; CONSTIPATION; DEFECATION; DISEASE SEVERITY; HUMAN; LIFESTYLE; QUALITY OF LIFE; REVIEW; SUPPOSITORY; VALIDATION PROCESS;

CATHARTICS; CONSTIPATION; DIET THERAPY; ENEMA; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; SUPPOSITORIES;

EID: 28844486799     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-005-1509-3     Document Type: Review

References (22)

1. Attar A, Lemann M, Ferguson A et al. (1999) Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation. Gut 44: 226-230
2. Corazziari E, Badiali D, Bazzocchi G et al. (2000) Long term efficacy, safety, and tolerability of low daily doses of isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in the treatment of functional chronic constipation. Gut 46: 522-526
3. DiPalma JA, DeRidder PH, Orlando RC, Kolts BE, Cleveland MB (2000) A randomized, placebo-controlled, multicenter study of the safety and efficacy of a new polyethylene glycol laxative. Am J Gastroenterol 95: 446-450
4. Erckenbrecht JF (2000) Epidemiologie der Obstipation. Z Gastroenterologie (Suppl 1): 3-5
5. Ewe K (1987) Effect of bisacodyl on intestinal electrolyte and water net transport and transit. Perfusion studies in men. Digestion 37: 247-253
6. Hammer HF, Hammer J, Gasche C (2000) Polyäthylenglykol (Macrogol) - Übersicht über seine Verwendung in der Diagnostik gastroenterologischer Erkrankungen. Wien Klin Wochenschr 112: 53-60
7. Hitzenberger G (1999) Konsensuspapier - Obstipation und Laxantien. Wien Med Wochenschr 149: 174-177
8. Kamm MA, Muller-Lissner S, Talley NJ et al. (2005) Tegaserod for the treatment of chronic constipation: a randomized, double-blind, placebo-controlled multinational study. Am J Gastroenterol 100: 362-372
9. Klauser AG, Peyerl C, Schindlbeck NE, Müller-Lissner SA (1992) Nutrition and physical activity in chronic constipation. Eur J Gastroenterol Hepatol 4: 227-233
10. Krammer HJ, Schlieger F, Harder H, Franke A, Singer MV (2005) Probiotika in der Therapie des Reizdarmsyndroms. Z Gastroenterol 43: 467-471
11. Mitznegg P, Schubert E, Domschke W, Strunz U, Schwemmle K, Demling L, Heim F (1975) Mode of action of bisacodyl (Dulcolax) on isolated muscles of human colon. Klin Wochenschr 15: 493-495
12. Müller-Lissner SA (1988) Effect of wheat bran on weight of stool and gastrointestinal transit time: a meta-analysis. BMJ 296: 615-617
13. Müller-Lissner SA (1992) Nebenwirkungen von Laxantien. Z Gastroenterol 30: 418-427
14. Müller-Lissner SA, Kamm MA, Scarpignato C, Wald A (2005) Myths and misconceptions about chronic constipation. Am J Gastroenterol 100: 232-242
15. Nyam DC, Pemberton JH, Ilstrup DM, Rath D (1997) Long-term results of surgery for chronic constipation. Dis Colon Rectum 40: 273-279
16. Prather CM, Camilleri M, Zinsmeister AR, McKinzies S, Thomforde G (2000) Tegaserod accelerates orocaecal transit in patients with constipation- predominant irritable bowel syndrome. Gastroenterology 118: 463-468
17. Ramkumar D, Rao SSC (2005) Efficacy and safety of traditional medical therapies for chronic constipation: Systemic review. Am J Gastroenterol 100: 936-971
18. Schäfer R (2000) Ballaststoffe in der Therapie der Obstipation. Z Gastroenterol (Suppl 1): 28-32
19. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA (1999) Functional bowel disorders and functional abdominal pain. Gut 45 (Suppl 2): II43-47
20. Verne GN, Eaker EY, Davis RH, Sninsky CA (1997) Colchicine is an effective treatment for patients with chronic constipation: an open-label trial. Dig Dis Sci 42: 1959-1963
21. Wedel T, Spiegler J, Soellner S, Roblick UJ, SchiedeckTHK, Bruch HP, Krammer HJ (2002) Enteric nerves and interstitial cells of Cajal are altered in patients with slow transit constipation and megacolon. Gastroenterology 123: 1459-1467
22. Wiseman LR, Faulds D (1994) Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders. Drugs 47: 116-152